| MC 2131 5-Bromovinyl-2'-deoxyuridine, [2-14C]- | |
| (Brivudine, [2-14C]-) | |
|  | |
| Ethanol:water (1:1) solution, 100 μCi/ml | Please Inquire for Pricing | 
| > 50 mCi(1.85 GBq)/mmol | |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 333.14 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MT 963 5-(Bromovinyl) 2'-deoxyuridine, [2'-3H]- (Discontinued) | |
| (Brivudine, [2'-3H]-) | |
|  | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq)/mmol | |
| NextGen V-Vial | |
| M.W. 333.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MT 1738 5-(Bromovinyl) 2'-deoxyuridine, [5'-3H]- (Discontinued) | |
| (Brivudine, [5'-3H]-) | |
|  | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq)/mmol | |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 333.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |